Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019027326) SCREENING METHOD
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/027326 International Application No.: PCT/NL2018/050535
Publication Date: 07.02.2019 International Filing Date: 03.08.2018
IPC:
G01N 33/50 (2006.01) ,G01N 33/66 (2006.01) ,A61K 31/00 (2006.01)
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
66
involving blood sugars, e.g. galactose
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
Applicants:
UNIVERSITEIT LEIDEN [NL/NL]; Rapenburg 70 2311 EZ Leiden, NL
Inventors:
SPAINK, Herman, Pieter; NL
Agent:
HGF BV; Zuid-Hollandlaan 7 2596 AL The Hague, NL
Priority Data:
201939004.08.2017NL
Title (EN) SCREENING METHOD
(FR) PROCÉDÉ DE CRIBLAGE
Abstract:
(EN) The present invention provides a method of screening a test compound for insulin resistance modulating activity. Corresponding methods for identifying a compound for treating diabetes and/or metabolic syndrome, and methods for identifying a target of a drug for the treatment of the same are also provided. Methods for optimising the formulation of a drug for the treatment of diabetes and/or metabolic syndrome are also provided herein.
(FR) La présente invention concerne un procédé de criblage d'un composé d'essai pour l'activité de modulation de la résistance à l'insuline. L'invention concerne également des procédés correspondants d'identification d'un composé pour le traitement du diabète et/ou du syndrome métabolique, et des procédés d'identification d'une cible d'un médicament pour le traitement de ces maladies. L'invention concerne en outre des procédés d'optimisation de la formulation d'un médicament pour le traitement du diabète et/ou du syndrome métabolique.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)